Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001638599-17-000133
Filing Date
2017-02-01
Accepted
2017-02-01 15:16:11
Documents
1
Period of Report
2017-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc3_4507.html 3  
1 PRIMARY DOCUMENT doc3_4507.xml 3 5760
  Complete submission text file 0001638599-17-000133.txt   7182
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3228 BROOKSIDE DRIVE FURLONG PA 18925
Business Address
Bass Gregory Brooks (Reporting) CIK: 0001696824 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36357 | Film No.: 17564602